Physician profile
Nancy A Burt
NPI 1407851223
$5,045.20
in general payments reported to CMS, 2019-2025
38 companies · $493 in 2025
The $493 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,342 · 2020: $942 · 2021: $164 · 2022: $1,218 · 2023: $372 · 2024: $515 · 2025: $493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,380.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,593.18 | 2021-2025 | Ubrelvy, Qulipta |
| Teva Pharmaceuticals USA, INC. | $626.14 | 2019-2023 | Ajovy, Austedo |
| Supernus Pharmaceuticals, INC. | $447.85 | 2019-2020 | |
| Acadia Pharmaceuticals INC | $278.19 | 2019-2020 | |
| Pfizer INC. | $215.74 | 2024 | |
| Emd Serono, INC. | $202.52 | 2019-2020 | |
| Genzyme Corporation | $176.21 | 2019-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $162.88 | 2022 | |
| Amgen INC. | $114.21 | 2019-2021 | |
| Allergan, INC. | $95.04 | 2019-2020 | |
| Mdd US Operations, LLC | $85.94 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $79.82 | 2019-2020 | |
| Medtronic, INC. | $78.50 | 2023-2025 | Sinuva, Intellis Adaptivestim |
| Argenx US, INC. | $76.75 | 2022 | |
| Ucb, INC. | $76.01 | 2019-2020 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $75.99 | 2019-2020 | |
| Csl Behring | $67.93 | 2019 | |
| Avanir Pharmaceuticals, INC. | $67.30 | 2019-2020 | |
| Amneal Pharmaceuticals LLC | $64.57 | 2019 | |
| Adamas Pharmaceuticals, INC. | $46.94 | 2019-2020 | |
| Lilly USA, LLC | $39.78 | 2020 | |
| Ge Healthcare | $37.35 | 2019 | |
| Impel Pharmaceuticals INC. | $36.47 | 2022 | |
| Assertio Therapeutics, INC. | $32.11 | 2019-2020 | |
| Livanova USA, INC. | $31.30 | 2019 | |
| Arbor Pharmaceuticals, INC. | $29.20 | 2019 | |
| Alk-Abello, INC | $22.98 | 2022 | |
| Sunovion Pharmaceuticals INC. | $22.83 | 2019 | |
| Inspire Medical Systems, INC. | $22.42 | 2025 | Inspire |
| Corium, LLC | $21.11 | 2023 | Adlarity |
| Biogen, INC. | $20.00 | 2021 | |
| Zyla Life Sciences, INC. | $14.93 | 2020 | |
| Neurocrine Biosciences, INC. | $14.88 | 2020 | |
| Lundbeck LLC | $14.44 | 2019 | |
| Acorda Therapeutics, INC | $13.91 | 2019 | |
| Natus Medical Incorporated | $13.77 | 2019 | |
| Upsher-Smith Laboratories LLC | $13.06 | 2019 | |
| Abbott Laboratories | $12.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Burt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.